GPRC5D Protein - ACROBiosystems

Home
Products

Products by Category

Recombinant proteins and more
Multi-pass Transmembrane Proteins and Technology PlatformsNew FDA DMF Filed ProteinsHot SARS-CoV-2 Related ProductsHot Immune Checkpoint ProteinsHot Targets of CAR-T Cell TherapyNew CytokinesHot Biosimilar Drug TargetsHot Tumor MicroenvironmentHot Anti-idiotypic AntibodyHot Fc Receptor Proteins Llama IgG Fc Fusion ProteinNew Bio-Markers & CD Antigens ActiveMax -Best Cytokines Viral Proteins Enzymes Antibodies All Recombinant Proteins

Pre-labeled proteins
Biotinylated protein collectionHot FITC & PE labeled ProteinsNew Fluorescent fusion proteins
Kits
SARS-CoV-2 Related Kit ProductsNew Pre-Coupling Magnetic BeadsNew ELISA Assay Kits for Quantitative Analysis of Therapeutic Antibodies in Serum Samples Inhibitor Screening Kits
Others
HPLC-verified Proteins Integrin - Integrin Proteins BCMA - B-Cell Maturation Antigen TIGIT - TIGIT Signaling Axis CD24 & Siglec-10 proteinsHot

Hot Products

Supports on COVID-19 R&D
Reagents for vaccine developmentNew Reagents for diagnostic developmentNew SARS-CoV-2 related productsNew SARS-CoV-2 related kitsNew SARS-CoV-2 mutant productsNew
Others
Multi-pass Transmembrane Proteins and Technology PlatformsNew Claudin18.2 ProteinsNew Bispecific antibody targetsHot Targets for ADCsHot IL-2 ReceptorsHot CD19 proteinsHot Anti-FMC63 mAbHot CD3 proteinsHot B7 family proteinsHot TNFSF proteinsHot VEGF proteinsHot CD39/CD73 proteinsNew Siglec-15 proteinsHot CD20 proteinsExclusive PD1 proteinsHot
Services

Innovation Lab
SPR /BLI analytical serviceNew Anti-Idiotypic AntibodyNew Enzyme-Linked Immunosorbent Assay (ELISA) Service New
Licensing Opportunities
Anti-TIM-3 monoclonal antibody New Anti-LAG-3 monoclonal antibody New Target 4-1BB monoclonal antibody New
Supports

How to Order Shipping & Payments Global Distributors Testimonials Download Brochures Download COA
Applications

The Process of How SARS-CoV-2 Infects the Host Quantitative Analysis of mAb in Serum Evaluation of CAR Expression
Company

About Us Join Us Contact Us
Activities

News Exhibitions Promotion
COVID-19 R&D ^New

GPRC5D

Brief Information

Name:G-protein coupled receptor family C group 5member D
Target Synonym:Orphan G-Protein Coupled Receptor,G Protein-Coupled Receptor Class C Group 5 Member D,G Protein-Coupled Receptor, Class C, Group 5, Member D,G Protein-Coupled Receptor, Family C, Group 5, Member D,G-Protein Coupled Receptor Family C Group 5 Member D,GPRC5

Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase 2 Clinical


GPD-H82D4	Human	Biotinylated Human GPRC5D Protein, His,Avitag™&Flag Tag (Nanodisc)
GPD-H52P5	Human	Human GPRC5D Full Length Protein-VLP (HEK293)
GPD-H52D3	Human	Human GPRC5D Protein, Flag,His Tag
GPD-H52D4	Human	Human GPRC5D Protein, Flag,His Tag (Nanodisc)

Cat. No.

Species

Product Description

Structure

Purity

Feature

GPD-H82D4

Human

Biotinylated Human GPRC5D Protein, His,Avitag™&Flag Tag (Nanodisc)

GPD-H52P5

Human

Human GPRC5D Full Length Protein-VLP (HEK293)

GPD-H52D3

Human

Human GPRC5D Protein, Flag,His Tag

GPD-H52D4

Human

Human GPRC5D Protein, Flag,His Tag (Nanodisc)

Synonym Name

GPRC5D

Background

G-protein coupled receptor family C group 5 member D (GPRC5D) is a retinoic acid-inducible 40 kDa protein with seven transmembrane segments and a short N terminal extracellular region. Widely expressed in the peripheral system. Expression pattern is high in pancreas, medium in kidney, small intestine, spleen and testis, low in lung, colon, leukocyte, prostate and thymus and not detectable in brain, heart, liver, placenta, skeletal muscle and ovary.

Clinical and Translational Updates

Clinical Drug Information

Name	Research Code	Research Phase	Company	Indications	Clinical Trials
Talquetamab	JNJ-7564; JNJ-64407564	Phase 2 Clinical	Janssen Global Services Llc, Genmab	Hematologic Neoplasms; Multiple Myeloma	Details
MCARH-109		Phase 1 Clinical	Memorial Sloan Kettering Cancer Center	Multiple Myeloma	Details